Delmed/NNP Inc./NNP 's/POS top/JJ two/CD officers/NNS resigned/VBD and/CC were/VBD succeeded/VBN *-2/-NONE- by/IN executives/NNS of/IN Fresenius/NNP USA/NNP Inc./NNP and/CC its/PRP$ parent/NN ,/, Fresenius/NNP AG/NNP ,/, a/DT major/JJ Delmed/NNP holder/NN that/WDT *T*-1/-NONE- has/VBZ been/VBN negotiating/VBG *-3/-NONE- to/TO acquire/VB a/DT controlling/JJ stake/NN ./.
In/IN addition/NN ,/, Delmed/NNP ,/, which/WDT *T*-2/-NONE- makes/VBZ and/CC sells/VBZ a/DT dialysis/NN solution/NN used/VBN */-NONE- in/IN */-NONE- treating/VBG kidney/NN diseases/NNS ,/, said/VBD 0/-NONE- negotiations/NNS about/IN pricing/NN *ICH*-1/-NONE- had/VBD collapsed/VBN between/IN it/PRP and/CC a/DT major/JJ distributor/NN ,/, National/NNP Medical/NNP Care/NNP Inc/NNP ./.
Delmed/NNP said/VBD 0/-NONE- Robert/NNP S./NNP Ehrlich/NNP resigned/VBD as/IN chairman/NN ,/, president/NN and/CC chief/JJ executive/NN ./.
Mr./NNP Ehrlich/NNP will/MD continue/VB as/IN a/DT director/NN and/CC a/DT consultant/NN ./.
Leslie/NNP I./NN Shapiro/NNP ,/, chief/JJ operating/VBG officer/NN and/CC chief/JJ financial/JJ officer/NN ,/, also/RB resigned/VBN ,/, the/DT company/NN said/VBD 0/-NONE- *T*-1/-NONE- ./.
Mr./NNP Ehrlich/NNP was/VBD succeeded/VBN *-1/-NONE- as/IN chairman/NN by/IN Gerd/NNP Krick/NNP ,/, a/DT director/NN of/IN Fresenius/NNP ,/, a/DT West/JJ German/JJ pharmaceutical/JJ concern/NN ./.
Ben/NNP Lipps/NNP ,/, president/NN of/IN Fresenius/NNP USA/NNP ,/, was/VBD named/VBN *-1/-NONE- president/NN ,/, chief/JJ executive/NN and/CC chief/JJ operating/VBG officer/NN ./.
None/NN of/IN the/DT officials/NNS was/VBD available/JJ for/IN comment/NN ./.
In/IN trading/NN on/IN the/DT American/NNP Stock/NNP Exchange/NNP ,/, Delmed/NNP closed/VBD at/IN 50/CD cents/NNS ,/, down/RB 6.25/CD cents/NNS ./.
Fresenius/NNP owns/VBZ about/IN 42/CD %/NN of/IN Delmed/NNP 's/POS fully/RB diluted/JJ common/JJ stock/NN ./.
The/DT two/CD companies/NNS have/VBP been/VBN discussing/VBG a/DT transaction/NN under/IN which/WDT Fresenius/NNP would/MD buy/VB Delmed/NNP stock/NN for/IN cash/NN *T*-2/-NONE- *-3/-NONE- to/TO bring/VB its/PRP$ beneficial/JJ ownership/NN to/TO between/IN 70/CD %/NN and/CC 80/CD %/NN *U*/-NONE- of/IN Delmed/NNP 's/POS fully/RB diluted/JJ common/JJ stock/NN ./.
The/DT transaction/NN also/RB would/MD combine/VB Fresenius/NNP USA/NNP and/CC Delmed/NNP ./.
Under/IN the/DT proposal/NN ,/, Delmed/NNP would/MD issue/VB about/IN 123.5/CD million/CD additional/JJ Delmed/NNP common/JJ shares/NNS to/TO Fresenius/NNP at/IN an/DT average/JJ price/NN of/IN about/IN 65/CD cents/NNS a/DT share/NN ,/, though/IN under/IN no/DT circumstances/NNS more/JJR than/IN 75/CD cents/NNS a/DT share/NN ./.
Yesterday/NN ,/, Delmed/NNP said/VBD 0/-NONE- it/PRP ``/`` continues/VBZ *-1/-NONE- to/TO explore/VB the/DT possibility/NN of/IN a/DT combination/NN with/IN Fresenius/NNP USA/NNP ./. ''/''
It/PRP added/VBD that/IN it/PRP *EXP*-2/-NONE- is/VBZ apparent/JJ that/IN any/DT terms/NNS of/IN a/DT combination/NN ``/`` would/MD be/VB substantially/RB less/RBR favorable/JJ than/IN those/DT previously/RB announced/VBN */-NONE- ./. ''/''
While/IN the/DT discussions/NNS between/IN Delmed/NNP and/CC National/NNP Medical/NNP Care/NNP have/VBP been/VBN discontinued/VBN *-1/-NONE- ,/, Delmed/NNP will/MD continue/VB *-2/-NONE- to/TO supply/VB dialysis/NN products/NNS through/IN National/NNP Medical/NNP after/IN their/PRP$ exclusive/JJ agreement/NN ends/NNS in/IN March/NNP 1990/CD ,/, Delmed/NNP said/VBD 0/-NONE- *T*-3/-NONE- ./.
In/IN addition/NN ,/, Delmed/NNP is/VBZ exploring/VBG distribution/NN arrangements/NNS with/IN Fresenius/NNP USA/NNP ,/, Delmed/NNP said/VBD 0/-NONE- *T*-1/-NONE- ./.

